Functionalized liposomes and niosomes for cancer therapy

Basit Öğe Kaydı
dc.authorscopusidAtefeh Zarepour / 56700291100
dc.authorscopusidAli Zarrabi / 23483174100
dc.authorwosidAtefeh Zarepour / AAH-9225-2020
dc.authorwosidAli Zarrabi / U-2602-2019
dc.contributor.authorYavari, Maryam
dc.contributor.authorSarrami Foroushani, Elnaz
dc.contributor.authorNasri, Negar
dc.contributor.authorZarepour, Atefeh
dc.contributor.authorZarrabi, Ali
dc.contributor.authorMostafavi, Ebrahim
dc.date.accessioned2025-04-18T10:06:23Z
dc.date.available2025-04-18T10:06:23Z
dc.date.issued2024
dc.departmentİstinye Üniversitesi, Mühendislik ve Doğa Bilimleri Fakültesi, Biyomedikal Mühendisliği Bölümü
dc.description.abstractLiposomes and niosomes are two members of lipid-based nanocarriers superfamily that have attracted lots of attention in the cancer therapy subject due to their interesting structural features. They are vesicular nanoparticles composed of cholesterol and phospholipid (liposomes) or surfactant (niosomes) that have the most similarity with cellular membranes and have the capability of loading both hydrophobic and hydrophilic therapeutic agents. Moreover, the surface of these carriers could be functionalized with different compounds to enhance their stability, bioavailability, and targeting ability, which finally could lead to improved therapeutic performance. This book chapter aims to discuss functionalized liposomal and niosomal therapeutic nanoparticles for cancer treatment. To this end, we will first describe different structural features of liposomes and niosomes and their different preparation methods. Then we will mention different generations of liposomes and niosomes as well as different types of functionalization that could affect the stability, loading capacity, and bioavailability of these carriers in targeted cancer tissue. © 2024 Elsevier Inc. All rights reserved.
dc.identifier.citationYavari, M., Foroushani, E. S., Nasri, N., Zarepour, A., Zarrabi, A., & Mostafavi, E. (2024). Functionalized liposomes and niosomes for cancer therapy. In Functionalized Nanomaterials for Cancer Research (pp. 345-363). Academic Press.
dc.identifier.doi10.1016/B978-0-443-15518-5.00028-8
dc.identifier.endpage363
dc.identifier.isbn978-044315518-5, 978-044315519-2
dc.identifier.scopus2-s2.0-85193377250
dc.identifier.scopusqualityN/A
dc.identifier.startpage345
dc.identifier.urihttps://hdl.handle.net/20.500.12713/6944
dc.indekslendigikaynakScopus
dc.institutionauthorZarepour, Atefeh
dc.institutionauthorZarrabi, Ali
dc.institutionauthoridAtefeh Zarepour/0000-0002-0347-5840
dc.institutionauthoridAli Zarrabi/0000-0003-0391-1769
dc.language.isoen
dc.publisherElsevier
dc.relation.ispartofFunctionalized Nanomaterials for Cancer Research: Applications in Treatments, Tools and Devices
dc.relation.publicationcategoryKitap Bölümü - Uluslararası
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectCancer Therapy
dc.subjectFunctional Nanomaterial
dc.subjectLiposome
dc.subjectNiosome
dc.subjectTargeting
dc.titleFunctionalized liposomes and niosomes for cancer therapy
dc.typeBook Chapter

Dosyalar

Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.17 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Biyomedikal Mühendisliği Bölümü Kitap Bölümü Koleksiyonu